The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luxembourg, A. T.
Right arrow Articles by Cai, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luxembourg, A. T.
Right arrow Articles by Cai, Z.
The Journal of Immunology, 1998, 161: 5226-5235.
Copyright © 1998 by The American Association of Immunologists

Requirements for Stimulating Naive CD8+ T Cells via Signal 1 Alone

Alain T. Luxembourg1,*, Anders Brunmark*, Yan Kong*, Michael R. Jackson*, Per A. Peterson*, Jonathan Sprent2,{dagger} and Zeling Cai3,*

* R. W. Johnson Pharmaceutical Research Institute, San Diego, CA 92121; and {dagger} Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037

In the absence of costimulation, TCR recognition of peptide/MHC complexes is generally considered to be nonimmunogenic. In agreement with this view, naive TCR transgenic CD8+ cells failed to respond to specific peptides presented by MHC class I (Ld) molecules bound to mouse RBC. However, peptide/Ld complexes presented by cell-sized beads or bound to plastic led to overt proliferative responses in the absence of added cytokines. Significantly, equivalent strong proliferative responses occurred when mouse RBC were fixed with glutaraldehyde before Ld coupling. The implication therefore is that the intensity of signaling via the TCR is a reflection of the mobility of the ligand being recognized; TCR signaling is weak when the ligand can move laterally on the cell membrane but strong when the ligand is immobilized.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Walter, L. Herrgen, O. Schoor, G. Jung, D. Wernet, H.-J. Buhring, H.-G. Rammensee, and S. Stevanovic
Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres
J. Immunol., November 15, 2003; 171(10): 4974 - 4978.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. H. Schafer, A. K. Gandhi, M. A. Loveland, R. S. Chen, H.-W. Man, P. P. M. Schnetkamp, G. Wolbring, S. Govinda, L. G. Corral, F. Payvandi, et al.
Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1222 - 1232.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Hwang, X. Shen, and J. Sprent
Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: Distinct roles for CD54 and B7 molecules
PNAS, May 27, 2003; 100(11): 6670 - 6675.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhai, L. Meng, F. Gao, R. W. Busuttil, and J. W. Kupiec-Weglinski
Allograft Rejection by Primed/Memory CD8+ T Cells Is CD154 Blockade Resistant: Therapeutic Implications for Sensitized Transplant Recipients
J. Immunol., October 15, 2002; 169(8): 4667 - 4673.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. D. Brown and D. Lillicrap
Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy
Blood, July 30, 2002; 100(4): 1133 - 1140.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-W. Mittrucker, M. Kursar, A. Kohler, R. Hurwitz, and S. H. E. Kaufmann
Role of CD28 for the Generation and Expansion of Antigen-Specific CD8+ T Lymphocytes During Infection with Listeria monocytogenes
J. Immunol., November 15, 2001; 167(10): 5620 - 5627.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Hwang and J. Sprent
Role of the Actin Cytoskeleton in T Cell Absorption and Internalization of Ligands from APC
J. Immunol., April 15, 2001; 166(8): 5099 - 5107.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Slavik, D.-G. Lim, S. J. Burakoff, and D. A. Hafler
Uncoupling p70s6 Kinase Activation and Proliferation: Rapamycin-Resistant Proliferation of Human CD8+ T Lymphocytes
J. Immunol., March 1, 2001; 166(5): 3201 - 3209.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhan, A. J. Corbett, J. L. Brady, R. M. Sutherland, and A. M. Lew
CD4 Help-Independent Induction of Cytotoxic CD8 Cells to Allogeneic P815 Tumor Cells Is Absolutely Dependent on Costimulation
J. Immunol., October 1, 2000; 165(7): 3612 - 3619.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. R. Rogers and M. Croft
CD28, Ox-40, LFA-1, and CD4 Modulation of Th1/Th2 Differentiation Is Directly Dependent on the Dose of Antigen
J. Immunol., March 15, 2000; 164(6): 2955 - 2963.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. W. Bingaman, J. Ha, S.-Y. Waitze, M. M. Durham, H. R. Cho, C. Tucker-Burden, R. Hendrix, S. R. Cowan, T. C. Pearson, and C. P. Larsen
Vigorous Allograft Rejection in the Absence of Danger
J. Immunol., March 15, 2000; 164(6): 3065 - 3071.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Sprent
Presidential Address to The American Association of Immunologists : Stimulating Naive T Cells
J. Immunol., November 1, 1999; 163(9): 4629 - 4636.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Sepulveda, A. Cerwenka, T. Morgan, and R. W. Dutton
CD28, IL-2-Independent Costimulatory Pathways for CD8 T Lymphocyte Activation
J. Immunol., August 1, 1999; 163(3): 1133 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Hauser, F. Zipprich, I. Leblond, S. Wirth, and A. W. Hugin
Protective Immunity from Naive CD8+ T Cells Activated In Vitro with MHC Class I Binding Immunogenic Peptides and IL-2 in the Absence of Specialized APCs
J. Immunol., July 1, 1999; 163(1): 330 - 336.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.